Molecular analysis of relationship between airway hyperreactivity and inflammation
Molecular analysis of relationship between airway hyperreactivity and inflammation
批准号:
15590828
负责人:
YAMASHITA Naomi
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
基因芯片分析显示,过敏原吸入后6h,CCL21(原次级淋巴组织趋化因子,SLC)和CCL19显著升高。CCL21是初始T细胞和抗原刺激的DC进入次级淋巴器官T细胞区的关键趋化因子,是抗原特异性T细胞活化的关键过程。在这项研究中,我们利用同时存在CCL21和CCL19基因表达缺陷的BALB/c-PLT/PLT小鼠(PLT小鼠),研究了CCL21在哮喘气道炎症中的作用。用卵白蛋白(OVA)和明胶免疫BALB/c小鼠4次,然后进行为期2周的OVA吸入治疗。虽然与BALB/c小鼠相比,气道炎症和对乙酰胆碱的反应显著减少,但PLT小鼠也观察到明显的嗜酸性炎症和高反应。停止吸入4周后,呼吸道炎症和高反应性…PLT小鼠的吞噬能力强于BALB/c小鼠。为了阐明呼吸道炎症延迟消退的机制,我们用流式细胞术分析了T细胞上CCR7、CCL19和CCL21的受体,因为有报道说CCR7的表达是T细胞从外周组织中退出的关键。PLT小鼠呼吸道内可见CD4+CCR7+细胞,但以CD4+CCR7-细胞为主。停止吸入OVA 7天后,PLT小鼠BALF中CD25阳性的CD4细胞数量和IL-10的产生明显少于BALB/c小鼠。综上所述,CCL21和CCL19不仅在诱导和缓解气道炎症中起关键作用。为了阐明T细胞在气道高反应性中的作用,我们重点研究了GATA-3,它是Th2细胞产生Th2细胞因子的必要条件,旨在阐明GATA-3高表达的T细胞在体内哮喘的病理生理学中的作用。使用携带GATA-3基因和卵清蛋白(OVA)特异性T细胞受体基因(GATA-3-TG(+))的双转基因小鼠。结果显示,GATA-3-TG(+)小鼠的呼吸道IL-13和IL-4蛋白水平显著升高。尽管GATA-3-Tg(+)组和GATA-3-Tg(-)组小鼠鼻腔注射OVA第7天时,GATA-3-Tg(+)组和GATA-3-Tg(-)组小鼠鼻腔注射乙酰胆碱后的反应性明显高于GATA-3-Tg(-)组,且GATA-3-Tg(-)组和GATA-3-Tg(-)组小鼠的免疫球蛋白E水平均未见明显升高。这种高反应性可被5-脂氧合酶抑制剂抑制。综上所述,哮喘的特征之一--呼吸道高反应性是通过在体内转录水平上控制淋巴细胞来诱导的。较少
英文摘要
Analysis using cDNA array revealed that CCL21 (formerly secondary lymphoid tissue chemokine, SLC) and CCL19 were significantly increased at 6 hours after allergen inhalation. CCL21 is a key chemokine in the entry of naive T cells and antigen-stimulated DCs into the T cell zones of secondary lymphoid organs, which is a critical process in antigen-specific T-cell activation. In the study, we investigated the role of CCL21 in airway inflammation in asthma using BALB/c-plt/plt mice (plt mice), which possess genetic defects in expression of both CCL21 and CCL19. Plt and control BALB/c mice were immunized with ovalbumin (OVA) and alum four times and thereafter were subjected to a two-week regimen of OVA inhalation. Although airway inflammation and response to acetylcholine were significantly reduced compared to BALB/c mice, significant eosinophilic inflammation and hyperresponsivenss were also observed in plt mice. Four weeks after cessation of inhalation, airway inflammation and hyperrespon … More siveness in plt mice were greater than in BALB/c mice. To clarify the mechanisms of delay in resolution of airway inflammation, we performed flow cytometric analysis to assess CCR7, receptor for CCL19 and CCL21 on T cell, because it has been reported that CCR7 expression is critical for T cell exit from peripheral tissues. There were CD4+CCR7+ cells but majority was CD4+CCR7- cells in the airway of plt mice. Seven days after cessation of OVA inhalation, number of CD25 positive CD4 cells and IL-10 production were significantly lesser in plt mice compared to BALB/c mice in the BALF. In conclusion, CCL21 and CCL19 were critical for not only induction but also resolution of airway inflammation.In order to clarify the role of T cell for airway hyperreactivity, we focused on GATA-3, which is essential for Th2 cells to produce Th2 cytokines and aimed to clarify the role of GATA-3 hyperexpressive T cells in the pathophysiology of bronchial asthma in vivo. Double transgenic mice carrying the GATA-3 gene and the ovalbumin (OVA)-specific T cell receptor gene (GATA-3-Tg (+)) were used. As a results, GATA-3-Tg (+) mice exhibited significantly higher IL-13 and IL-4 protein at the airway. Although there was no difference in infiltrated cells between GATA-3-Tg(+) and GATA-3-Tg(-) and no significant increase in IgE level in either group compared to non-treated mice, the response after acetylcholine inhalation was significantly elevated in GATA-3-Tg(+) than in GATA-3-Tg(-) on the seventh day of intranasal treatment with OVA. This hyperresponsiveness was inhibited by 5-lipoxygenase inhibitor. In conclusion, airway hyperresponsiveness, a characteristic of bronchial asthma, was induced by controlling lymphocytes at the transcriptional level in vivo. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Aminophilline suppress the release of chemical mediators in treatment of acute asthma.
Aminophilline 在治疗急性哮喘时抑制化学介质的释放。
DOI:
--
发表时间:
2006
期刊:
Respir Med (in press)
影响因子:
--
作者:
[Nakano J, Yano T, Yamamura K, Yoshihara H, Ohbayashi O, Ymashita N, Ohta, K]
通讯作者:
K
Association of transforming growth factor-beta1 single nucleotide polymorphism C-509T with allergy and immunological activities.
转化生长因子-β1 单核苷酸多态性 C-509T 与过敏和免疫活性的关联。
DOI:
--
发表时间:
2005
期刊:
Int Arch Allergy Immunol.
影响因子:
--
作者:
[Meng J, Thongngarm T, Nakajima M, Yamashita N, Ohta K, Bates CA, Grunwald GK, Rosenwasser LJ.]
通讯作者:
Rosenwasser LJ.
Association of transforming growth factor-beta 1 single nucleotide polymorphism C-509T with allergy and immunological activities.
转化生长因子-β1 单核苷酸多态性 C-509T 与过敏和免疫活性的关联。
DOI:
--
发表时间:
2005
期刊:
Int Arch Allergy Immunol.
影响因子:
--
作者:
[Meng J, Thongngarm T, Nakajima M, Yamashita N, Ohta K, Bates CA, Grunwald GK, Rosenwasser LJ.]
通讯作者:
Rosenwasser LJ.
DOI:
10.1152/ajplung.00195.2005
发表时间:
2006-06-01
期刊:
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
影响因子:
4.9
作者:
[Yamashita, N, Tashimo, H, Ohta, K]
通讯作者:
Ohta, K
山下直美: "炎症細胞のアポトーシスからみた病態と治療"ICUとCCU. 28. 19-24 (2003)
Naomi Yamashita:“从炎症细胞凋亡的角度进行病理学和治疗”ICU 和 CCU。 28. 19-24 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Information Support for Caregivers of Depressed Individuals
-
批准号:24650434
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2012
-
负责人:YAMASHITA Naomi
-
依托单位:
Bronchial epithelial cells as the targets of the therapy for refractory asthma of elderly patients.
-
批准号:22590075
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:YAMASHITA Naomi
-
依托单位:
Molecular biologic approach for chronic and irractable asthma-analysis for mechanism of remodeling using murine asthmatic model
-
批准号:11670459
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:YAMASHITA Naomi
-
依托单位:
Regulation of allergic inflammation by the induction T cell anergy
-
批准号:08670538
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1997
-
负责人:YAMASHITA Naomi
-
依托单位:
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
-
批准号:30873315
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:周兆山
-
依托单位:
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
-
批准号:30740048
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2007
-
负责人:李海潮
-
依托单位:
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
-
批准号:30672268
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2006
-
负责人:符州
-
依托单位: